Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Soleno Therapeutics Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +2 vs. Q1 2023
- Shares held
- 5.10M
- +1.78M (+53.7%) vs. Q1 2023
- Total value
- $21.8M
- +$14.7M (+208.8%) vs. Q1 2023
- New holders
- 3
- 3 more added
- Sold out
- 1
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 2,207,753 | $9.47M | 0.28% | +2,207,753 | New |
| Carlyle Group Inc. | 1,201,506 | $5.09M | 0.18% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 649,841 | $2.79M | 0.34% | −49,523−7.1% | Reduced |
| AIGH Capital Management LLC | 364,306 | $1.56M | 0.64% | −58,183−13.8% | Reduced |
| Birchview Capital, LP | 245,127 | $1.05M | 0.79% | 00.0% | Unchanged |
| J. Goldman & Co LP | 120,799 | $518.2K | 0.03% | −148,644−55.2% | Reduced |
| Worth Venture Partners, LLC | 90,858 | $389.8K | 0.21% | −13,055−12.6% | Reduced |
| Renaissance Technologies LLC | 66,054 | $283.0K | 0.00% | −10,461−13.7% | Reduced |
| Geode Capital Management, LLC | 54,648 | $234.4K | 0.00% | +22,092+67.9% | Added |
| Vanguard Group Inc | 49,939 | $214.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 24,966 | $107.1K | 0.00% | −5,173−17.2% | Reduced |
| State Street Corp | 15,448 | $66.3K | 0.00% | 00.0% | Unchanged |
| Bollard Group LLC | 2,288 | $10.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,093 | $8.98K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 871 | $3.74K | 0.00% | +800+1,126.8% | Added |
| Tower Research Capital LLC (TRC) | 731 | $3.14K | 0.00% | −2,083−74.0% | Reduced |
| BlackRock Inc. | 342 | $1.47K | 0.00% | 00.0% | Unchanged |
| VisionPoint Advisory Group, LLC | 168 | $721 | 0.00% | +168 | New |
| Wells Fargo & Company | 40 | $172 | 0.00% | +2+5.3% | Added |
| Group One Trading, L.P. | 37 | $159 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 15 | $64 | 0.00% | +15 | New |
| JPMorgan Chase & Co | 6 | $26 | 0.00% | −69,869−100.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Clayton Partners LLC | 0 | $0 | 0.00% | −92,772−100.0% | Sold out |